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Patients were classified in relation to BMI. Blood samples for
the evaluation of adiponectin, leptin and MMP-3 were
collected. A 12-core transrectal prostate biopsy was performed.
Serum adiponectin, leptin and MMP-3 were measured using
“Human Leptin Instant ELISA”, “Human Adiponectin ELISA”,
“Human MMP-3 ELISA” kits, respectively. Statistical analysis
was performed to relate the plasmatic levels of the above-
mentioned biomarkers to the presence of Gleason patterns 4
and 5 at biopsy. Results: Fifty-six patients were enrolled.
Median serum levels of leptin, adiponectin and MMP-3 were
0.829 ng/ml, 1.72 ng/ml and 1.767 ng/ml, respectively. In
relation to BMI class, the plasmatic levels of leptin and MMP-
3 were higher in obese (p=0.02) and in normal-weight patients
(p=0.02), respectively. No statistically significant difference
was detected in serum levels of leptin (p=0.18), adiponectin
(p=0.68) and MMP-3 (p=0.49) between the 24 patients
(42.8%) with diagnosis of PCa and the 30 patients (53.7%)
with a negative biopsy. Comparing the levels of biomarkers in
11/24 patients (45.8%) with Gleason 6 (3+3) and in 13/24
(54.2%) showing Gleason patterns 4 and 5 at biopsy, again, no
statistically significant difference in leptin (p=0.4), adiponectin
(p=0.6) and MMP-3 (p=0.5) levels was found. Conclusion: In
our preliminary study, we found increased plasmatic levels of
leptin and MMP-3 in obese and normal-weight patients
undergoing prostate biopsy, respectively. The significance of
this finding, in patients with an elevated PSA, is uncertain. On
the other hand, no other statistical difference was found
between BMI, plasmatic levels of leptin, adiponectin, MMP-3
and detection of an aggressive Gleason pattern at biopsy.
We wish to thank the GSTU Foundation for the administrative
support.
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Figure 1. 360 overall histological measures.
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Introduction/Aim: Tumor excision is a fundamental step during
partial nephrectomy (PN), yet resection technique (RT) is
rarely reported in current nephron-sparing surgery (NSS)
literature. We recently proposed the Surface-Intermediate-Base
(SIB) margin score as a new classification model for
standardized reporting of RT during NSS. The aim of the study
was to validate the SIB model from a histopathological
perspective. Materials and Methods: Data were prospectively
collected from a cohort of 40 patients undergoing NSS,
between June and September 2014, at a single Institution. The
SIB score was assigned in the operating room by the surgeon.
The score-specific areas (SSA) were outlined on a digital
picture as anatomic landmarks for histopathological analysis.
Two dedicated uropathologists inked the landmark areas and
measured, in a blinded fashion, the maximum, minimum and
mean thickness of healthy renal margin (HRM) within the
SSAs (360 overall histologic measures, Figure 1). The Mann-
Whitney U-test was used to assess the correlation between the
SIB visual definitions of RTs and the thickness of HRM at
histopathological analysis. Results: The overall RT was
classified as pure enucleation, hybrid enucleation and pure
enucleoresection in 28 (70%), 7 (17%) and 3 (7%) patients,
respectively, while as hybrid enucleoresection and resection in
1 (3%) patient each. At histopathological analysis, the
maximum, minimum and mean thickness of HRM was
significantly different among SSAs visually defined as
enucleation (S=0: median=0.18mm (interquartile range
(IQR)=0.08-0.30), I or B=0: median=0.20 mm (IQR=0.08-
0.36)), enucleoresection (S=1: median=0.80 mm (IQR=0.67-
1.16), I, B=1: median=0.88 mm (IQR=0.60-1.00)) and
resection (S=1, I, B=2: median=2.95 mm (IQR=2.18-5.75)
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Figure 2. Box-plots showing the minimum (Min), mean and maximum (Max) thickness of healthy renal margin (HRM) for the score-specific
area (SSA) – grades Surface=0 (S=0), Surface=1 (S=1), Intermediate or Base=0 (I or B=0), Intermediate or Base=1 (I or B=1) and
Intermediate or Base=2 (I or B=2). Median values and interquartile ranges (white boxes) are shown. Thickness of HRM was significantly
different between both the SSA-grades S=0 and S= 1 (p<0,001) and the SSA-grades I or B=0, I or B=1 and I or B=2 (p<0,001), for all
histological measures (maximum, minimum and mean values). S, surface; I, intermediate; B, base.
(Figure 2) (p<0.001). Conclusion: The SIB margin score is the
first standardized reporting system to communicate RT during
NSS. Our study proved the applicability of the model in a real-
world clinical setting and provided robust histopathological
validation of its utility. 
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Introduction: Despite differences in outcomes, due to
heterogeneity in study designs, a wealth of clinical and
experimental evidences underscore the beneficial effects of
the consumption of lycopene-rich tomatoes on prostate
functions (1). Such effect, which is maximally reached using
cooked tomatos, has been shown to be dose-dependent (2).
Thus, development of tomato-processing methods aimed at
optimally preserving the health-promoting activity of this fruit
that is of major translational relevance. Materials and
Methods: Using the transgenic adenocarcinoma of the mouse
prostate (TRAMP) model, the effect of a diet enriched with
processed whole tomato on animal survival, tumorigenesis
and progression was investigated. Results: Tomato-enriched
diet significantly increased overall survival, delayed
progression from prostatic intraepithelial neoplasia to
adenocarcinoma and decreased the incidence of poorly
differentiated carcinoma. This was paralleled by an increase
of plasma antioxidant capacity and a reduction of circulating
pro-inflammatory and pro-angiogenic cytokines of known
relevance in human prostate carcinogenesis. Based on these
preclinical data, we have developed a dietary supplement
containing a blend of ad-hoc processed whole tomato and
olive vegetation water for human use, called Lycoprozen®
(Italian Health Ministry, code 68843) (3). Conclusion: This
new dietary supplement may help to maintain prostate health
and can contribute to the beneficial effect of adherence to the
WCRF/AICR recommendations, especially when proper life
styles are adopted.
1 Raiola A, Rigano MM, Calafiore R, Frusciante L and
Barone A: Enhancing the Health-Promoting Effects of
Tomato Fruit for Biofortified Food. Mediators Inflamm
2014: 139873, 2014. 
2 Er V, Lane JA, Martin RM, Emmett P, Gilbert R, Avery KN,
Walsh E, Donovan JL, Neal DE, Hamdy FC and Jeffreys M:
Adherence to dietary and lifestyle recommendations and
prostate cancer risk in the prostate testing for cancer and
treatment (ProtecT) trial. Cancer Epidemiol Biomarkers Prev
23: 2066-2077, 2014.
3 Tomato powder based composition. PCT, Publication No.
WO/2015/044134 A1.
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Introduction/Aim: Rare histotypes represent almost 10% of
bladder tumors, although more often represented as small foci
within large and invasive transitional cell tumors of the bladder
(TCCB). It might be clinically relevant that rare histological
variants remain unrecognized at transurethral resection
(TURBT), since they could indicate more aggressive tumors,
less responsive to systemic chemotherapy and unfit for “organ-
sparing” management. We investigated the accuracy of TURBT
to detect rare histological variants in patients-candidates to
cystectomy for bladder cancer with clinical and radiological
features of invasiveness. Materials and Methods: The clinical
and pathologic data of 340 patients submitted to TURBT and/or
cystectomy for bladder cancer, between January 2010 and July
2015, were reviewed. The presence of uncommon histotypes
within urothelial bladder carcinoma has been assessed. The
diagnosis of rare variants of bladder cancer was made according
to WHO criteria. Standard hematoxilyn-eosin stain was adopted
and further immunohistochemistry was performed as follows:
Micro-papillary carcinoma, MUC1, EMA, CK7, CK20;
Squamous cell carcinoma, CK5/6, CK5/14; Adenocarcinoma,
CK7, CK20, CEA, EMA; Small cell carcinoma, EMA,
CAM5.2, synaptophysin, vimentin, chromogranin, neuro-
specific enolase (NSE), CK7, c-kit and TTF1; Mesenchymal
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